SCHEMBL19660438

SCHEMBL19660438

CCc1cncc2c(C)cccc12

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.44
CYP1A2 P05177 2/20 0.44
ALDH1A1 P00352 1/20 0.39
GABRA1 P14867 2/20 0.34
GABRB2 P47870 2/20 0.34
ELANE P08246 2/20 0.33
CYP19A1 P11511 2/20 0.33
NLRP3 Q96P20 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PARP1 P09874 2/20 0.33
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
BRD4 O60885 1/20 0.32
CREBBP Q92793 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19660419 0.85 CYP1A2 (0.44) CYP2A6CYP1A2ALDH1A1CYP19A1LMNA
SCHEMBL19725752 0.84 GABRA1 (0.41) CYP1A2ALDH1A1GABRA1GABRB2ELANE
SCHEMBL20012925 0.79 NOS2 (0.41) ALDH1A1GABRA1GABRB2LMNASMN1; SMN2
SCHEMBL8404557 0.77 CYP1A2 (0.62) CYP2A6CYP1A2ALDH1A1ELANEL3MBTL1
SCHEMBL599157 0.77 CYP1A2 (0.62) CYP2A6CYP1A2ALDH1A1GABRA1GABRB2
SCHEMBL21237367 0.77 GABRA1 (0.35) ALDH1A1GABRA1GABRB2NLRP3LMNA
SCHEMBL19660431 0.73 KDM5A (0.37) CYP2A6CYP1A2
SCHEMBL19663002 0.72 CYP1A2 (0.48) CYP2A6CYP1A2ALDH1A1
SCHEMBL19953988 0.72 CYP1A2 (0.48) CYP2A6CYP1A2ALDH1A1ELANEL3MBTL1
SCHEMBL13765864 0.72 CYP1A2 (0.48) CYP2A6CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 WO disclosed